Chapter 10: Analgesic Drugs

The chapter establishes foundational pain physiology by exploring nociception and the gate control theory, which explains how pain signals are transmitted and modulated throughout the nervous system. Understanding opioid receptor pharmacology is essential, as mu, kappa, and delta receptors mediate different analgesic effects and contribute to varying side effect profiles. The chapter categorizes pain into distinct types including acute, chronic, visceral, somatic, neuropathic, phantom, and cancer pain, each requiring tailored management strategies. Students learn to differentiate between pain threshold and pain tolerance while recognizing how cultural factors influence pain expression and treatment preferences. Nonopioid analgesics such as acetaminophen and nonsteroidal anti-inflammatory drugs form the foundation of mild to moderate pain management, while opioid agonists including morphine, fentanyl, hydromorphone, and oxycodone address moderate to severe pain. The chapter introduces opioid agonist-antagonist medications like buprenorphine and pure antagonists such as naloxone, clarifying their distinct clinical roles. Critical nursing responsibilities encompass calculating equianalgesic doses, implementing patient-controlled analgesia systems, managing breakthrough pain episodes, and monitoring for tolerance and physical dependence. Safety considerations including black box warnings, respiratory depression, constipation, and sedation are thoroughly addressed. Adjuvant medications such as antidepressants, anticonvulsants, and corticosteroids enhance analgesia for specific pain types. The chapter integrates nonpharmacologic interventions including acupuncture, massage, hypnosis, and physical therapy as complementary strategies. The World Health Organization analgesic ladder and Joint Commission standards provide evidence-based frameworks guiding clinical decision-making and ensuring ethical, compassionate pain management centered on patient needs and safety.